Eight triterpenoids, six lanostanes 1-6, one lupenane 7, and one oleanane 8, were isolated by bioactivity-guided fractionation of the ethylacetate extract from roots of Glycine max (L.) Merr. All isolated compounds were examined for their inhibitory activities against human ACAT-1 (hACAT-1) and human ACAT-2 (hACAT-2). Among them, three triterpenoids showed potent hACAT inhibitory activities, (24R)-ethylcholest-5-ene-3,7-diol (1) and 3β-hydroxylup-20(29)-en-28-oic acid (7) exhibited more potent inhibitory activity against hACAT-1 (1: IC 50 = 25.0 ± 1.2 and 7: IC 50 = 11.5 ± 0.4 μM) than hACAT-2 (1: IC 50 = 102.0 ± 5.4 and 7: IC 50 = 33.9 ± 3.7 μM), respectively. Interestingly, 5α,8α-epidioxy-24(R)-methylcholesta-6,22-diene-3β-ol (4) has proven to be a specific inhibitor against hACAT-1 (IC 50 = 38.7 ± 0.8 μM) compared to hACAT-2 (IC 50 > 200).
Introduction
Acyl-CoA: cholesterol acyltransferase (ACAT, E.C. 2.3.1.26) is an allosteric enzyme that catalyzes the acylation of cholesterol to cholesteryl esters with long chain fatty acids, which is a very attractive target for the prevention and treatment of cardiovascular diseases and hypercholesterolemia. [1] [2] [3] In mammalian species, two isoforms such as ACAT-1 and ACAT-2 exhibited different tissue distribution and membrane. 4, 5 In humans, ACAT-1 performs a critical role in the formation of macrophage foam cells, whereas ACAT-2 is in charge of the cholesterol absorption process in intestinal enterocytes. 6, 7 Therefore, ACAT inhibitors are being investigated as potent therapeutic agents in the treatment of both atherosclerosis and hypercholesterolemia. 8 In our search for ACAT inhibitors from natural sources, we found that the EtOAc extract of Glycine max (L.) Merr. roots exhibited inhibitory activities against hACAT-1 and hACAT-2 with 82% and 59% inhibition at 100 μg/mL, respectively. Soybeans (G. max) are one of the most produced and commercialized commodities worldwide with not only high amounts of protein and oil but also several phytochemicals. [9] [10] [11] [12] It is well established that isoflavones are responsible for the biological activities of soybean. 13 Even though researchers mainly have focused on secondary metabolites of soybean because of their potential medicinal values including antioxidant, 14 anticancer, 15 and antiatherosclerotic activities, 16 their application concerning ACAT inhibitor has so far not been reported. Recently, we were the first to report evaluation of low-density lipoprotein (LDL)-antioxidant pterocarpans concerning atherosclerosis from this species. 17 In this study, the isolation of phytochemicals from G. max, bioactivity-guided fractionations, using hACAT inhibitory activity measurements led to the isolation of three potent hACAT inhibitors 1, 4, and 7 as well as five triterpenoids. Moreover here, we describe the isolation, structure characterization, and hACAT inhibitory activities.
Results and Discussion
The methanolic extract of the dried roots of G. max showed a strong inhibition upon hACAT. Solvent partition of the methanolic extract resulted in the localization of the active compounds in EtOAc-soluble fraction. Further bioactivity-guided fractionation of combined EtOAc fraction using hACAT inhibitory activity, yielded eight triterpenoids isolated by repeated column chromatography, Sephadex LH-20, and recrystallization. These compounds 1-8 were identified as (24R)-ethylcholest-5-ene-3,7-diol (1), (24R)-ethylcholest-5-en-3-ol-7-one (2), (24R)-ethylcholestane-3,7-diol (3), 5α,8α-epidioxy-24(R)-methylcholesta-6,22-diene-3β-ol (4), 24(R)-methylcholesta-5,7,22-tiene-3-ol (5), 17-acetoxy-4,4-dimethyl-24-methylene-5-cholesta-8,14-diene-3,11-diol (6), 3β-hydroxylup-20(29)-en-28-oic acid (7), and 12-oleanene-3β,22β, 3,22,24-triol (8) , respectively, by analyses of spectroscopic data and comparison of their physical data previously reported (Figure 1) . [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Among them, three compounds 4, 7, and 8 could be obtained in gram amount (4: 1.9 g, 7: 1.1 g, and 8: 2.1 g, respectively) as the dominant triterpenoids constituents. Moreover, five compounds 1, 2, 4, 5, and 7 were first isolated from this plant.
Although a large number of reports have been issued on the biological activities of G. max, there is no report on the component of soybean which inhibits hACAT. The isolated triterpenoids 1-8 from G. max roots have been evaluated for the first time for their inhibitory activities on hACAT-1 and hACAT-2 for the development of useful antiatherogenic and hyperchole-sterolemic substances. The rate of incorporation of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] oleoyl-CoA into cholesteryl ester was determined using the expressed hACAT-1 and hACAT-2 from Hi5 cells and oleic acid anilide was used as positive control. 29 As shown in Table 1 , three triterpenoids 1, 4, and 7 showed potent hACAT inhibitory activities, whereas the other compounds exhibited a very weak or no inhibitory activities. The compounds 1, 4, and 7 were detected to inhibit hACAT-1 and hACAT-2 activities in a dose-dependent manner with significant hACAT inhibitory effects observed at 10-100 μM Table 1) . Among other lanostane-type triterpenoids, 5α,8α-epidioxy-24(R)-methylcholesta-6,22-diene-3β-ol (4) exhibited relatively high hACAT-1 inhibitory activity with IC 50 value of 38.7 ± 0.8 μM, although inhibition of the hACAT-2 activity was barely detected (> 200 μM). Allyl alcohol group in B-ring of lanostane skeleton may play a role as a key functionality for inhibitory activity on hACAT. Because compound 1 has allyl alcohol in B-ring apparently a In vitro ACAT inhibitory activity was measured using expressed hACAT-1. and hACAT-2. Data are shown as mean values of three independent experiments performed in triplicate (Mean ± S.D., n = 3).
b Percentage at 25 μM.
c NI: no inhibition. and compound 4 has 1,2-dioxinyl group that could be transformed to allyl alcohol functionality in aqueous condition easily. In lupenane-type triterpenoids, 3β-hydroxylup-20(29)-en-28-oic acid (7) showed the most potent inhibitory activities against both hACAT-1 and hACAT-2 with IC 50 values of 11.5 ± 0.4 and 33.9 ± 3.7 μM, respectively, which was in accordance with our previous report. 30 This result suggested that lanostane-type triterpenoids 1 and 4 and lupenane-type triterpenoids 7 in soybean could be expected as hACAT inhibitors.
Experimental Section
General Experimental Procedures. Melting points were measured on a Thomas Scientific capillary melting point apparatus (Electrothermal 9300, UK) and are uncorrected. IR spectra were recorded on a Bruker IFS66 (Bruker, karlsruhe, Germany) infrared Fourier transform spectrophotometer (KBr) and Extraction and Isolation. The dried roots of G. max (2.0 kg) were chopped and extracted three times (6 L × 3) with methanol for 10 days at room temperature. The concentrated methanolic extract (98.0 g) was suspended in H 2 O and successively partitioned with n-hexane (1.0 L), EtOAc (1.5 L), and n-BuOH (1.2 L), which yielded a n-hexane (10.4 g), EtOAc (29.8 g), and n-BuOH (12.6 g) extracts. The EtOAc extract showed potent inhibitory activities against hACAT-1 and hACAT-2 with 82% and 59% inhibition at 100 μg/mL, respectively, which was chromatographed on a silica gel (6 × 60 cm, 230-400 mesh, 680 g), eluting a step gradient of The chemical shifts of compounds 1, 2, 4, and 5 were determined in CDCl3, and compound 7 was measured in DMSO-d6.
were concentrated and submitted to a silica gel column chromatography (2.5 × 50 cm, 130 g, 230-400 mesh) eluting with CHCl 3 -acetone (10:1 → 1:1) and rechromatographed on a Sephadex LH-20 (1.5 × 50 cm) for elution with methanol in order to yield compound 6 (39 mg). The spectroscopic data of five isolated triterpenoids were described as follows and the other compounds were described as previously reported. Table 2 . Table 2 .
Inhibitory Activity against hACAT. The microsomal fractions of Hi5 cells containing baculovirally expressed hACAT-1 and hACAT-2 were used as sources of the enzyme. 29 The inhibitory activities of hACAT-1 and hACAT-2 were determined as previously described with some slight modifications. 18, 31 Briefly, the reaction mixture, which con- In conclusion, we reported eight triterpenoids 1-8 isolated from roots of G. max and examined their hACAT inhibitory activities. Especially, three triterpenoids 1, 4, and 7 exhibited high inhibitory activities against hACAT-1 (1: 25.0 ± 1.2, 4:
38.7 ± 0.8, and 7: 11.5 ± 0.4 μM, respectively) and hACAT-2 (1: 102.0 ± 5.4, 4: > 200, and 7: 33.9 ± 3.7 μM, respectively). This is nevertheless the first report to demonstrate that triterpenoids of G. max showed potent inhibitory activities against hACAT-1 and hACAT-2. Further studies on hACAT inhibitory activity for the treatment of hypercholesterolemia and atherosclerosis are under investigation.
